Daqian Xu

机构：Zhejiang Chinese Medical University, Harbin Medical University, Zhejiang Cancer Hospital, Zhejiang University-University of Edinburgh Institute, Hangzhou Cancer Hospital, First Affiliated Hospital Zhejiang University, Zhejiang University · ORCID：0000-0003-0478-2997

发表论文 78 篇 · 总被引 5201 次 · h-index 32

代表论文

• Glycolytic enzyme PFKL governs lipolysis by promoting lipid droplet–mitochondria tethering to enhance β-oxidation and tumor cell proliferation (2024 · Nature Metabolism · 被引 144)
• ADSL-generated fumarate binds and inhibits STING to promote tumour immune evasion (2025 · Nature Cell Biology · 被引 42)
• Sphingolipid synthesis in tumor-associated macrophages confers immunotherapy resistance in hepatocellular carcinoma (2025 · Science Advances · 被引 32)
• PSAT1 impairs ferroptosis and reduces immunotherapy efficacy via GPX4 hydroxylation (2025 · Nature Chemical Biology · 被引 27)
• ADSL promotes autophagy and tumor growth through fumarate-mediated Beclin1 dimethylation (2025 · Nature Chemical Biology · 被引 25)
• Lipid metabolism reprograming by SREBP1‐PCSK9 targeting sensitizes pancreatic cancer to immunochemotherapy (2025 · 癌症：英文版 · 被引 24)